CTNNB1 and hepatocellular carcinoma: We posit that the NR phenotype during late-stage HCC LNP-CTNNB1 treatment reflected a lack of sustained active lymphocyte proliferation, infiltration, and response to IFNβ signaling in the intra-tumoral compartment.